Our data show survivors had mean IL-6 levels of 177.9 + /- 227.9 whereas non-survivors had mean levels of 1384.2 + /- 1234.7 congruent with reports that elevated IL-6 levels are associated with poor outcomes in patients with COVID19 viral pneumonia4,5. The gene discussed is IL6; the disease is COVID-19.